Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Metabolic and body compositional consequences of GH deficiency (GHD) in adults are associated with a phenotype similar to the metabolic syndrome (MetS). PATIENTS: We assessed MetS prevalence in adult GHD patients (n = 2531) enrolled in the Hypopituitary Control and Complications Study. Prevalence was assessed at baseline and after 3 yr of GH replacement in a subset of 346 adult-onset patients. RESULTS: Baseline MetS crude prevalence was 42.3%; age-adjusted prevalence in the United States and Europe was 51.8 and 28.6% (P < 0.001), respectively. In the United States, age-adjusted prevalence was significantly higher (P < 0.001) than in a general population survey. Increased MetS risk at baseline was observed for age 40 yr or older (adjusted relative risk 1.34, 95% confidence interval 1.17-1.53, P < 0.001), females (1.15, 1.05-1.25, P = 0.002), and adult onset (1.77, 1.44-2.18, P < 0.001). In GH-treated adult-onset patients, MetS prevalence was not changed after 3 yr (42.5-45.7%, P = 0.172), but significant changes were seen for waist circumference (62.1-56.9%, P = 0.008), fasting glucose (26.0-32.4%, P < 0.001), and blood pressure (59.8-69.7%, P < 0.001). Significantly increased risk of MetS at yr 3 was associated with baseline MetS (adjusted relative risk 4.09, 95% confidence interval 3.02-5.53, P < 0.001) and body mass index 30 kg/m(2) or greater (1.53, 1.17-1.99, P = 0.002) and increased risk (with a P value < 0.1) for GH dose 600 microg/d or greater (1.18, 95% confidence interval 0.98-1.44, P = 0.088). CONCLUSION: MetS prevalence in GHD patients was higher than in the general population in the United States and higher in the United States than Europe. Prevalence was unaffected by GH replacement, but baseline MetS status and obesity were strong predictors of MetS after GH treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes
McNutt, L.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg074 · Cited by 2,096
Easy SAS Calculations for Risk or Prevalence Ratios and Differences
Spiegelman, D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi188 · Cited by 1,738
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationGrundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000111245.75752.c6 · Cited by 718
Statistical Methods in Cancer Research, Vol. II: The Design and Analysis of Cohort Studies.
Machin, D., Breslow, N. E., & Day, N. E. (1990) · Biometrics · doi:10.2307/2532481 · Cited by 634
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Self-citationAge standardization of death rates: implementation of the year 2000 standard.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 612
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Self-citationColao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450
Williams, T., Berelowitz, M., Joffe, S. N., Thorner, M. O., Rivier, J., Vale, W., & Frohman, L. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112203 · Cited by 428
Attanasio, A. F., Lamberts, S. W. J., Matranga, A. M. C., Birkett, M. A., Bates, P. C., Valk, N. K., Hilsted, J., Bengtsson, B.-Å., & Strasburger, C. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3643 · Cited by 380
Self-citationThe growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375 · cited 5×
“J Clin Endocrinol Metab, January 2010, 95(1):74–81 jcem.”
BackgroundInfluentialMaison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Self-citationCorneli, G., Di Somma, C., Baldelli, R., Rovere, S., Gasco, V., Croce, C. G., Grottoli, S., Maccario, M., Colao, A., Lombardi, G., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01967 · Cited by 317
Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Arondel, D., Vol, S., Tichet, J., & Eschwège, E. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70067-8 · Cited by 268
The DECODE Study Group, & Qiao, Q. (2006) · Diabetologia · doi:10.1007/s00125-006-0438-6 · Cited by 200
Estimated Number of Adults With Prediabetes in the U.S. in 2000
Benjamin, S. M., Valdez, R., Geiss, L. S., Rolka, D. B., & Narayan, K. M. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.645 · Cited by 191
Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency
Besson, A., Salemi, S., Gallati, S., Jenal, A., Horn, R., Mullis, P. S., & Mullis, P. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021938 · Cited by 168
Bülow, B., Hagmar, L., Eskilsson, J., & Erfurth, E. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6346 · Cited by 142
Self-citationAbs, R., Feldt-Rasmussen, U., Mattsson, A. F., Monson, J. P., Bengtsson, B.-A., Góth, M. I., Wilton, P., & Koltowska-Häggström, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02179 · Cited by 140
Bramnert, M., Segerlantz, M., Laurila, E., Daugaard, J. R., Manhem, P., & Groop, L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020542 · Cited by 134
Attanasio, A. F. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1600 · Cited by 132
Self-citationMartínez-Larrad, M. T., Fernández, C., González‐Sánchez, J. L., López, A., Fernández-Álvarez, J., Riviriego, J., & Serrano‐Ríos, M. (2005) · Medicina Clínica · doi:10.1157/13080210 · Cited by 130
A 10-Year, Prospective Study of the Metabolic Effects of Growth Hormone Replacement in Adults
Götherström, G., Bengtsson, B.-A., Bosæus, I., Johannsson, G., & Svensson, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1487 · Cited by 122
Bonert, V. S., Elashoff, J. D., Barnett, P., & Melmed, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032213 · Cited by 117 · cited 1×
“This aspect has been taken into account in the biochemical diagnosisofGHDbystandardizing theGHresponse in stimulation tests for the degree of existing obesity (12, 13).”
BackgroundRosenfalck, A. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4173 · Cited by 115
Growth hormone and the metabolic syndrome.
Johannsson, G., & Bengtsson, B. Å. (1999) · PubMed · Cited by 113
Hwu, C.-M., Kwok, C. F., Lai, T.-Y., Shih, K.-C., Lee, T.-S., Hsiao, L.-C., Lee, S.-H., Fang, V. S., & Ho, L.-T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4311 · Cited by 105
Inflammatory cardiovascular risk markers in women with hypopituitarism
Sesmilo, G., Miller, K. K., Hayden, D., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8087 · Cited by 97 · cited 1×
“Such higher risk in females has been reported in adult hypopituitary GHD patients (30, 31), and a recent study in 750 adult Swedish GHD patients found an increased prevalence of type 2 diabetes mellitus in women compared with men (32), suggesting that aspects specifically related to GHD or hypopituitarism may contribu…”
BackgroundChristopher, M., Hew, F. L., Oakley, M., Rantzau, C., & Alford, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4836 · Cited by 89
Menezes Oliveira, J. L., Marques-Santos, C., Barreto-Filho, J. A., Ximenes Filho, R., de Oliveira Britto, A. V., Oliveira Souza, A. H., Prado, C. M., Pereira Oliveira, C. R., Pereira, R. M. C., de Almeida Ribeiro Vicente, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2571 · Cited by 88
van der Klaauw, A. A., Biermasz, N. R., Feskens, E. J. M., Bos, M. B., Smit, J. W. A., Roelfsema, F., Corssmit, E. P. M., Pijl, H., Romijn, J. A., & Pereira, A. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0699 · Cited by 86
Verhelst, J., Kendall-Taylor, P., Erfurth, E. M., Price, D. A., Geffner, M., Koltowska-Häggström, M., Jönsson, P. J., Wilton, P., & Abs, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0185 · Cited by 72
Self-citationYuen, K. C. J., Frystyk, J., White, D. K., Twickler, T. B., Koppeschaar, H. P. F., Harris, P. E., Fryklund, L., Murgatroyd, P. R., & Dunger, D. B. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02359.x · Cited by 67
Wabitsch, M., Moss, A., Denzer, C., & Fischer‐Posovszky, P. (2012) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-012-2623-7 · Cited by 63
Webb, S. M., Strasburger, C. J., Mo, D., Hartman, M. L., Melmed, S., Jung, H., Blum, W. F., Attanasio, A. F., & on behalf of the HypoCCS International Advisory Board (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0713 · Cited by 59
Self-citationHolmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B., Thorén, M. C., Höybye, C., Degerblad, M., Bramnert, M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0458 · Cited by 45
Self-citationUntreated growth hormone deficiency explains premature mortality in patients with hypopituitarism
Bengtsson, B.-Å. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80014-2 · Cited by 22
Sönksen, P. H. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0155 · Cited by 5
Cited by
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
The Association Between IGF-I and Insulin Resistance
Friedrich, N., Thuesen, B., Jørgensen, T., Juul, A., Spielhagen, C., Wallaschofksi, H., & Linneberg, A. (2012) · Diabetes Care · doi:10.2337/dc11-1833 · Cited by 283
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Gazzaruso, C., Gola, M., Karamouzis, I., Giubbini, R., & Giustina, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2394 · Cited by 151
Metadata
- Authors
- Attanasio, A. F., Mo, D., Erfurth, E. M., Tan, M., Ho, K. Y., Kleinberg, D., Zimmermann, A. G., & Chanson, P.
- Affiliations
- Eli Lilly (United States) (US)
- Skåne University Hospital (SE)
- New York University (US)
- Université Paris-Sud (FR)
- Corresponding author
- Chanson, Philippe
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-01
- Volume
- 95
- Issue
- 1
- Pages
- 74-81
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2122247204
- Semantic Scholar
- e83a667e4304f5a7ecead74853c76d0b499fee84
- Cited by
- 115
- References
- 47
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 4 · 2015: 5 · 2014: 12 · 2013: 6 · 2012: 13
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- metabolic syndrome, adult-onset growth hormone deficiency, growth hormone replacement therapy, hypopituitarism, prevalence, waist circumference, fasting blood glucose, blood pressure, body mass index, body composition, sex differences, obesity risk, cardiovascular risk factors, diabetes risk, dyslipidemia, hypertension, insulin resistance
- MeSH terms
- Adult, Aged, Female, Follow-Up Studies, Growth Disorders, Humans, Hypopituitarism, Male, Middle Aged, Obesity, Cohort Studies, Prevalence, Human Growth Hormone, Hormone Replacement Therapy, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.